Foundation Medicine Inc, has announced to day that its shareholders has approved the pending strategic transaction with Roche. Roche to purchase up to 15.6 million shares of FMI common stock at a price of $50 per share.
View the full release here.
Foundation Medicine Inc, has announced to day that its shareholders has approved the pending strategic transaction with Roche. Roche to purchase up to 15.6 million shares of FMI common stock at a price of $50 per share.
View the full release here.